Product Images Nabumetone

This appears to be a medication label for Nabumetone tablets, with each tablet containing 500mg of the active ingredient. The label also includes details on dosage and storage instructions, as well as the name and address of the manufacturer, "SciGen".*

The text appears to be a label of medication for Nabumetone tablets, with each tablet containing 500 mg of the drug. The label provides information on the usual dosage, storage instructions, and precautions to be taken while using the medication. It also mentions the name of the manufacturer as SciGen.*

Each tablet contains nabumetone USP, 750 mg. The usual dosage is to store at a controlled room temperature between 20°C to 25°C (68°F to rhésasensss). Dispense in a light-resistant container as defined in the USP. An accompanying medication guide should be given to each patient and must be kept out of the reach of children. The product is manufactured by Actavis Pharma, Inc. of Hauppauge, NY 11768.*

This is a medication label for Nabumetone tablets. Each tablet contains 750mg of nabumetone USP. The usual dosage is to be determined by the prescribing information. The tablet must be stored at 20°C to 25°C but excursions are allowed between 15°C to 30°C. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. The manufacturer is ScieGen Pharmaceuticas, Inc. with the NDC code 50228-466-05. This is a prescription medication and patients should receive the accompanying medication guide.*

This is a chart showing the plasma concentrations of the active metabolite (BMNA) of Nabumetone at steady state, following once-daily dosing of either 1000mg or 2000mg. There were 31 participants in the 1000mg group and 12 in the 2000mg group. The chart includes time in hours on the X-axis and plasma concentrations of BMNA on the Y-axis. There is no further information available.*